NCT00755924已完成1 期
Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 114
- 试验地点
- 1
- 主要终点
- Change in HDL-Cholesterol level
研究概览
简要总结
This is a double-blinded randomized placebo controlled prospective clinical trial evaluating the impact of apple cider vinegar on serum HDL. 112 participants will be randomized to consume either 2 tablespoons of vinegar daily or a placebo containing a 2% balsamic vinegar solution in water. Baseline, two month and 4 month blood samples will be obtained for fasting lipids. The primary endpoint is met if HDL levels increase in the treatment arm versus baseline after 2 month intervention.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Those older than 18 years of age
- •Park Nicollet Health Services patient
排除标准
- •Because of a potential positive effect of vinegar on improving diabetes mellitus8 and the subsequent change in medication regime for diabetes diabetic patients will be excluded from this study. If this study finds that vinegar does increase HDL levels, a subsequent study of diabetic patients will be conducted.
- •History of allergy to apple cider vinegar
- •Those with a terminal illness
- •Diagnosis of Inflammatory bowel disease
- •Those with Immunosuppression diseases
- •Patients on dialysis
- •Severe psychiatric illness who are unable to consent or reliably participate
- •No evidence of end stage renal disease
- •Those who use alcohol greater than or equal to 2 drinks per day
- •Those who take in >3 tsp vinegar/day supplement
- •Plans to increase exercise or begin diet during the protocol period
- •Any use of niacin or niacin-like compounds
- •Initiation of niacin, fibrates (eg gemfibrozil); statin or ezetimibe medication within the last 6 weeks or during the trial
- •Inability to read English
- •Age less than 18 years given clinical events would be unlikely in this population
- •LDL greater than 160mg/dL and requires adjustment or addition of statin therapy (which could reduce HDL)
- •History of liver failure in medical history review
- •Current smoking (as this can reduce HDL levels and it would be unethical to require people to continue smoking during the study)
结局指标
主要结局
Change in HDL-Cholesterol level
时间窗: 12 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
2 期
NSAID RCT for Prevention of Altitude SicknessSpectrum of Altitude-associated Neurologic Forms of AltitudeNCT01606527Naval Health Research Center300
已完成
2 期
Efficacy of Rifaximin in Preventing CampylobacteriosisDiarrheaEnteric CampylobacteriosisDysenteryNCT02280044Johns Hopkins Bloomberg School of Public Health30
招募中
2 期
Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.Allergic Transfusion ReactionNCT04688736Institute of Hematology & Blood Diseases Hospital, China6,642
已完成
2 期
A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)COVID-19NCT04566770CanSino Biologics Inc.480
已完成
4 期
Study on the Effects of Intravenous Dexmedetomidine on Pain in Patients Undergoing Elective Spinal SurgeryChronic PainNCT03325972NYU Langone Health83